Introducing GSK GSK homepage Downloads Annual report
Product portfolio



Back Next
  Seretide/Advair RESPIRATORY  
   


Seretide/Advair

 
     

£208m/$316m

A combination of Serevent and Flixotide that offers a long-acting bronchodilator and an anti-inflammatory in a single inhaler.

 

  
         
         
      back to list  

 
    Updated March 22, 2001 - © 2001 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement
Introducing GSK
Chairman and CEO
Business operating review
Corporate citizenship
Product portfolio
Corporate executive team
Summary financials
Summary remuneration report
Responsibility statements
Corporate governance
The board
Shareholder return
Shareholder information
Contact details